8DB5 | pdb_00008db5

Crystal structure of the GDP-D-glycero-4-keto-d-lyxo-heptose-3,5-epimerase from Campylobacter jejuni, serotype HS:15


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free: 
    0.236 (Depositor), 0.241 (DCC) 
  • R-Value Work: 
    0.189 (Depositor), 0.196 (DCC) 
  • R-Value Observed: 
    0.191 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8DB5

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

C3- and C3/C5-Epimerases Required for the Biosynthesis of the Capsular Polysaccharides from Campylobacter jejuni .

Ghosh, M.K.Xiang, D.F.Thoden, J.B.Holden, H.M.Raushel, F.M.

(2022) Biochemistry 61: 2036-2048

  • DOI: https://doi.org/10.1021/acs.biochem.2c00364
  • Primary Citation Related Structures: 
    8DAK, 8DB5, 8DCL, 8DCO

  • PubMed Abstract: 

    Campylobacter jejuni is a human pathogen and one of the leading causes of food poisoning in Europe and the United States. The outside of the bacterium is coated with a capsular polysaccharide that assists in the evasion of the host immune system. Many of the serotyped strains of C. jejuni contain a 6-deoxy-heptose moiety that is biosynthesized from GDP-d- glycero -d- manno -heptose by the successive actions of a 4,6-dehydratase, a C3/C5-epimerase, and a C4-reductase. We identified 18 different C3/C5-epimerases that could be clustered together into three groups at a sequence identity of >89%. Four of the enzymes from the largest cluster (from serotypes HS:3, HS:10, HS:23/36, and HS:41) were shown to only catalyze the epimerization at C3. Three enzymes from the second largest cluster (HS:2, HS:15, and HS:42) were shown to catalyze the epimerization at C3 and C5. Enzymes from the third cluster were not characterized. The three-dimensional structures of the epimerases from serotypes HS:3, HS:23/36, HS:15, and HS:41 were determined to resolutions of 1.5-1.9 Å. The overall subunit architecture places these enzymes into the diverse "cupin" superfamily. Within X-ray coordinate error, the immediate regions surrounding the active sites are identical, suggesting that factors extending farther out may influence product outcome. The X-ray crystal structures are consistent with His-67 and Tyr-134 acting as general acid/base catalysts for the epimerization of C3 and/or C5. Two amino acid changes (A76V/C136L) were enough to convert the C3-epimerase from serotype HS:3 to one that could now catalyze the epimerization at both C3 and C5.


  • Organizational Affiliation
    • Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.

Macromolecule Content 

  • Total Structure Weight: 175.1 kDa 
  • Atom Count: 12,942 
  • Modeled Residue Count: 1,412 
  • Deposited Residue Count: 1,472 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
GDP-D-glycero-4-keto-d-lyxo-heptose-3,5-epimerase
A, B, C, D, E
A, B, C, D, E, F, G, H
184Campylobacter jejuniMutation(s): 0 
Gene Names: HS58.11
EC: 5.1.3.13
UniProt
Find proteins for A0A0S2CFK0 (Campylobacter jejuni subsp. jejuni)
Explore A0A0S2CFK0 
Go to UniProtKB:  A0A0S2CFK0
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A0S2CFK0
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
GDP

Query on GDP



Download:Ideal Coordinates CCD File
I [auth A]
K [auth B]
M [auth C]
N [auth D]
P [auth E]
I [auth A],
K [auth B],
M [auth C],
N [auth D],
P [auth E],
Q [auth E],
T [auth G],
V [auth H]
GUANOSINE-5'-DIPHOSPHATE
C10 H15 N5 O11 P2
QGWNDRXFNXRZMB-UUOKFMHZSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
J [auth A]
L [auth B]
O [auth D]
R [auth E]
S [auth F]
J [auth A],
L [auth B],
O [auth D],
R [auth E],
S [auth F],
U [auth G],
W [auth H]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free:  0.236 (Depositor), 0.241 (DCC) 
  • R-Value Work:  0.189 (Depositor), 0.196 (DCC) 
  • R-Value Observed: 0.191 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 41.549α = 90
b = 154.525β = 91.28
c = 120.506γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
PDB_EXTRACTdata extraction
SAINTdata reduction
SADABSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM139428
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM122825
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM134643

Revision History  (Full details and data files)

  • Version 1.0: 2022-06-22
    Type: Initial release
  • Version 1.1: 2022-09-28
    Changes: Database references
  • Version 1.2: 2022-10-05
    Changes: Database references
  • Version 1.3: 2023-10-18
    Changes: Data collection, Refinement description